Aidoc
Stub active Updated Apr 30, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
About
Aidoc is a clinical AI company whose CARE foundation model and aiOS enterprise platform are deployed in nearly 2,000 hospitals worldwide, having analyzed more than 110 million patient cases and supporting decision-making for roughly 60 million patients each year 12.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-29 | Series E | $150M | Goldman Sachs Alternatives Growth Equity | General Catalyst, SoftBank Vision Fund 2, NVentures (NVIDIA), Hartford HealthCare, Mercy, Sutter Health, WellSpan Health 123 |
What Investors Say
No independently sourced investor quotes found for this round.
What Founders Say
No independently sourced founder quotes found for this round.
Sources
-
Aidoc, “Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI for Earlier, Safer Diagnoses,” April 29, 2026. https://www.aidoc.com/about/news/aidoc-raises-150-million-series-e-led-by-goldman-sachs-to-scale-clinical-ai-for-earlier-safer-diagnoses/↩↩
-
PR Newswire, “Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI for Earlier, Safer Diagnoses,” April 29, 2026. https://www.prnewswire.com/news-releases/aidoc-raises-150-million-series-e-led-by-goldman-sachs-to-scale-clinical-ai-for-earlier-safer-diagnoses-302757181.html↩↩
-
Axios, “Exclusive: Clinical AI provider Aidoc raises $150M Series E,” April 29, 2026. https://www.axios.com/2026/04/29/exclusive-clinical-ai-provider-aidoc-raises-150m-series-e↩